HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 08, August 2019 – Digitalization vs Digitization — Exploring Emerging Trends in Healthcare       » Shanghai neurologists test brain implant to tackle drug addiction       » Gene-editing researchers reduce cancer risk       » Artificial Intelligence in Precision Cancer Diagnostics: Myth or Magic?       » Healing with Technology       » Smart Hospital: An Instrument of Care       » Transforming Healthcare with Data and Artificial Intelligence      
BIOBOARD For e-subscribers (PDF)
Vol 23, No. 08, August 2019
ASIA-PACIFIC
MIT's research enterprise in Singapore (SMART) launches new research group, boosting nation's cell therapy R&D

New research group launched by SMART, Critical Analytics for Manufacturing Personalized-Medicine (CAMP) as part of Singapore's National Cell Manufacturing Initiative

Potential cancer treatment strategies for humans from mechanisms behind low cancer occurrence in bats.

A new study reveals that a protein present in higher amounts in bats compared to humans may contribute to their low cancer incidence.

Singapore scientists uncover mechanism behind development of viral infections

Clinical trial findings provide new insights to differential responses to flaviviral infections.

Exosomes found to aid in fighting Dengue infection New area for exosome research shows potential therapeutic strategy for treating Dengue Fever.
National platforms created to accelerate Singapore's drug development efforts

Collaborations between research institutions and healthcare providers look to enhance the competitive edge in drug discovery for Singapore's biomedical ecosystem.

REST OF THE WORLD
Cybersecurity company threat report details cyberattacks targeting the healthcare industry

Report highlights input from 20 leading healthcare Chief Information Security Officers (CISOs) who offer their perspective on evolving cyberattacks, ransomware and the biggest concerns to their organizations.

Artificial intelligence - designed influenza vaccine begins clinical trials in the US

More effective seasonal flu vaccine to be tested in clinical trials.

Clinical - stage biotechnology company presents Murlentamab phase II study results in colorectal cancer.

GamaMabs Pharma, developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II (AMHRII) for the treatment of cancer, announces the oral presentation of clinical data from its phase II study of murlentamab in metastatic colorectal cancer (mCRC)

NEWS CRUNCH  
news How blockchain can save the food industry millions from recalls
news China Healthcare and Pharma Digital Innovation Summit
news BIO-PHARM2019 — The Most Influential Forum in China's Biopharm Industry
news The rise of personalised nutrition
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy